U.S. RESEARCH ROUNDUP Argenx SE, Novo Nordisk, UMB Financial

1 minute read
Register now for FREE unlimited access to Reuters.com

Jan 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Argenx SE, Novo Nordisk and UMB Financial, on Tuesday.

HIGHLIGHTS

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

Register now for FREE unlimited access to Reuters.com
Compiled by Bengaluru Newsroom

Our Standards: The Thomson Reuters Trust Principles.